Gastroparesis
Delayed gastric emptying: etiology, diagnosis with 4-hour GES, dietary management, glycemic optimization, prokinetics (metoclopramide REMS), antiemetics, and interventional therapies including G-POEM โ ACG 2022.
Definition, etiology, symptoms, gastric emptying
Gastroparesis: Delayed Emptying Without Obstruction
Gastroparesis is a chronic symptomatic disorder characterized by delayed gastric emptying in the absence of mechanical obstruction. It impairs quality of life significantly and represents a major management challenge in clinical gastroenterology.
Other etiologies: connective tissue disorders (scleroderma, EDS), Parkinson's disease, hypothyroidism, medications (opioids, GLP-1 agonists, anticholinergics), post-COVID, paraneoplastic.
Cardinal Symptoms (Cardinal Symptom Index โ GCSI)
Abdominal pain occurs in ~90% of patients but is not a primary diagnostic feature โ distinguish from functional dyspepsia.
Gastroparesis vs. Functional Dyspepsia
Significant symptom overlap exists between gastroparesis and functional dyspepsia (FD). ACG 2022 emphasizes that delayed gastric emptying is NOT required for a diagnosis of functional dyspepsia, and ~30โ40% of FD patients have delayed emptying. Management may be similar. Gastroparesis diagnosis requires objective documentation of delayed emptying on standardized testing.
Medication-Induced Gastroparesis โ Screen First
Before extensive workup, review medications. Opioids, GLP-1 receptor agonists (semaglutide, liraglutide), anticholinergics, TCAs, and calcium channel blockers all delay gastric emptying. Discontinue offending agents and reassess before confirming a diagnosis.
Camilleri M et al. ACG Clinical Guideline: Gastroparesis. Am J Gastroenterol. 2022;117(8):1197โ1220.